C2 Ceramide [3102-57-6]
Référence HY-101180-5mg
Conditionnement : 5mg
Marque : MedChemExpress
C2 Ceramide (Ceramide 2) is the main lipid of the stratum corneum and a protein phosphatase 1 (PP1) activator. C2 Ceramide activates PP2A and ceramide-activated protein phosphatase (CAPP). C2 Ceramide induces cells differentiation, autophagy and apoptosis, inhibits mitochondrial respiratory chain complex III. C2 Ceramide is also a skin conditioning agent that protects the epidermal barrier from water loss.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
C2 Ceramide Chemical Structure
CAS No. : 3102-57-6
This product is a controlled substance and not for sale in your territory.
Based on 1 publication(s) in Google Scholar
Description |
C2 Ceramide (Ceramide 2) is the main lipid of the stratum corneum and a protein phosphatase 1 (PP1) activator. C2 Ceramide activates PP2A and ceramide-activated protein phosphatase (CAPP). C2 Ceramide induces cells differentiation, autophagy and apoptosis, inhibits mitochondrial respiratory chain complex III. C2 Ceramide is also a skin conditioning agent that protects the epidermal barrier from water loss[1][2][3][4][5]. |
IC50 & Target |
Protein phosphatase 1[2] |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cellular Effect |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In Vitro |
C2 Ceramide (5 nM-200 μM; 24 hours; primary mouse osteoblasts) treatment (≤500 nM) promots osteoblast viability, whilst concentrations ≥2 μM significantly reduces osteoblast viability in a dose- and time-dependent manner[1]. MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Cell Viability Assay[1]
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In Vivo |
The PP1 activator C2 Ceramide increases alkaline phosphatase activity, mineralizes nodule formation, and mRNA expression of dentin matrix protein 1 and dentin sialophosphoprotein. In contrast, knockdown by PP1 small interfering RNA inhibits odontoblastic differentiation[2]. MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Masse moléculaire |
341.53 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Formule |
C20H39NO3 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CAS No. |
3102-57-6 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Appearance |
Solid |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Color |
White to off-white |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SMILES |
O[C@H](/C=C/CCCCCCCCCCCCC)[C@H](CO)NC(C)=O |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Livraison | Room temperature in continental US; may vary elsewhere. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stockage |
-20°C, sealed storage, away from moisture *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Solvant et solubilité |
In Vitro:
DMSO : 20 mg/mL (58.56 mM; Need ultrasonic and warming; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO) Ethanol : 17 mg/mL (49.78 mM; Need ultrasonic and warming) Preparing
Stock Solutions
View the Complete Stock Solution Preparation Table
*
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol) Concentration (start) × Volume (start) = Concentration (final) × Volume (final) This equation is commonly abbreviated as: C1V1 = C2V2 In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:
Dosage mg/kgAnimal weight Dosing volume Number of animals Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Calculation results:
Working solution concentration:
mg/mL
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pureté et documentation |
Purity: 99.85%
SDS (252 KB)
COA (240 KB) HNMR (279 KB) RP-HPLC (241 KB) MS (70 KB) Instruction de manipulation (2659 KB) |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Références |
|
Complete Stock Solution Preparation Table
*
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
---|
Ethanol / DMSO | 1 mM | 2.9280 mL | 14.6400 mL | 29.2800 mL | 73.2000 mL |
5 mM | 0.5856 mL | 2.9280 mL | 5.8560 mL | 14.6400 mL | |
10 mM | 0.2928 mL | 1.4640 mL | 2.9280 mL | 7.3200 mL | |
15 mM | 0.1952 mL | 0.9760 mL | 1.9520 mL | 4.8800 mL | |
20 mM | 0.1464 mL | 0.7320 mL | 1.4640 mL | 3.6600 mL | |
25 mM | 0.1171 mL | 0.5856 mL | 1.1712 mL | 2.9280 mL | |
30 mM | 0.0976 mL | 0.4880 mL | 0.9760 mL | 2.4400 mL | |
40 mM | 0.0732 mL | 0.3660 mL | 0.7320 mL | 1.8300 mL | |
DMSO | 50 mM | 0.0586 mL | 0.2928 mL | 0.5856 mL | 1.4640 mL |
C2 Ceramide Related Classifications
- Metabolic Enzyme/Protease Apoptosis Autophagy
- Phosphatase Mitochondrial Metabolism Apoptosis Autophagy